A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction

<div>The calibration curve for predicting major adverse cardiovascular events probability at (a) 1 year and (b) 2 years in the evaluation cohort and at (c) 1 year and (d) 2 years in the validation cohort. Nomogram-predicted probability of major adverse cardiovascular events is plotted on the <i>X</i>-axis; actual probability is plotted on the <i>Y</i>-axis.</div>

Cardiovascular Therapeutics

fig3

Figure 3

Figure 3: A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction 

Figure 3 | A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction 